Speaker illustration

Doctor Giuseppina Milano

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)

Rimeporide, a first in class Na/H exchanger-1 inhibitor, ameliorates right ventricular dysfunction and pulmonary arterial hypertension in a SuHx model

Event: ESC Congress 2023

Topic: Cardiac Hypertrophy

Session: Myocardial remodelling (1)


Cardiopulmonary effects of nitric oxide supplementation in a model of chronic hypoxia pulmonary hypertension

Event: ESC Congress 2019

Topic: Pathophysiology and Mechanisms

Session: Hypertension - Miscellaneous


Chronic hypoxia selectively impairs autophagy in the right ventricle in a model of pulmonary hypertension

Event: ESC Congress 2017

Topic: Haemodynamics, heart and hypertension

Session: Hypertension treatment (drugs and devices)


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb